Michael Emig
Impact in
- Gastroenterology top 1%
- Gastrointestinal Tumor Research and Treatment
- Pulmonary and Respiratory Medicine top 0.5%
- Gastric Cancer Management and Outcomes
- Lung Cancer Treatments and Mutations
Papers in
-
- Gastric Cancer Management and Outcomes 16
- Lung Cancer Treatments and Mutations 10
- Lung Cancer Diagnosis and Treatment 4
- Oncology 16
- Colorectal Cancer Treatments and Studies 9
- Co-authors
- Eric Van Cutsem (14 shared papers)Kei Muro (12 shared papers)H. Wilke (11 shared papers)G. Bodoky (12 shared papers)Atsushi Ohtsu (10 shared papers)Kumari Chandrawansa (8 shared papers)Naotoshi Sugimoto (7 shared papers)Shuichi Hironaka (7 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Blood (7 papers)Leukemia (4 papers)Annals of Oncology (3 papers)Journal of Neuroimmunology (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Michael Emig
43 papers receiving 3.9k citations
Michael Emig's Hit Papers
Peers
Comparison fields: 5 of 100
- Gastroenterology 346
- Pulmonary and Respiratory Medicine 2.0k
- Oncology 1.5k
- Hematology 462
- Genetics 309
Countries citing papers authored by Michael Emig
This map shows the geographic impact of Michael Emig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Emig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Emig more than expected).
Fields of papers citing papers by Michael Emig
This network shows the impact of papers produced by Michael Emig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Emig. The network helps show where Michael Emig may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Emig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial Hit paper breakdown → | 2014 | 1743 |
| 2 | Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial Hit paper breakdown → | 2009 | 1051 |
| 3 | 1999 | 207 | |
| 4 | 2000 | 150 | |
| 5 | 2008 | 130 | |
| 6 | 2006 | 93 | |
| 7 | 2000 | 74 | |
| 8 | 2014 | 65 | |
| 9 | 2016 | 59 | |
| 10 | 2005 | 57 | |
| 11 | 2016 | 55 | |
| 12 | 2017 | 50 | |
| 13 | 1996 | 26 | |
| 14 | 1996 | 26 | |
| 15 | 2000 | 20 | |
| 16 | 2017 | 16 | |
| 17 | 2014 | 16 | |
| 18 | Cetuximab plus platinum-based chemotherapy as 1st-line treatment in patients with non-small cell lung cancer (NSCLC): a meta-analysis of randomized phase II/III trials | 2009 | 15 |
| 19 | 2014 | 14 | |
| 20 | 2014 | 11 |
About Michael Emig
Michael Emig is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hematology, Genetics and Surgery, having authored 47 papers that have together received 4.0k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (16 papers), Chronic Myeloid Leukemia Treatments (10 papers), Lung Cancer Treatments and Mutations (10 papers), Colorectal Cancer Treatments and Studies (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Eosinophilic Disorders and Syndromes (5 papers) and Lung Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Gastroenterology (346 citations), Pulmonary and Respiratory Medicine (2.0k citations), Oncology (1.5k citations), Hematology (462 citations) and Genetics (309 citations). Michael Emig has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Eric Van Cutsem, Kei Muro, H. Wilke, G. Bodoky, Atsushi Ohtsu, Kumari Chandrawansa, Naotoshi Sugimoto, Shuichi Hironaka, Yasuhiro Shimada and Oleg Lipatov. Their work appears in journals such as Journal of Clinical Oncology, Blood, Leukemia, Annals of Oncology and Journal of Neuroimmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.